Epsilon Healthcare Limited

EPN

AU0000137598

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 23:37:33 17/12/2023 GMT			5-day change	1st Jan Change
0.024 ^AUD	-.--%		-.--%	-.--%

07-08	Epsilon Healthcare Limited Announces Termination of Xiao Cui as Company Secretary	CI
07-04	Epsilon Healthcare Comes Out of Voluntary Administration	MT

Epsilon Healthcare Limited Announces Termination of Xiao Cui as Company Secretary

July 08, 2024 at 05:31 am

Epsilon Healthcare Limited announced that the services of Mr. Xiao (Josh) Cui as Company Secretary of Epsilon has been terminated effective immediately and Mr. Marcelo Mora continues to be Company Secretary of Epsilon.

Latest news about Epsilon Healthcare Limited

Epsilon Healthcare Limited Announces Termination of Xiao Cui as Company Secretary	07-08	CI
Epsilon Healthcare Comes Out of Voluntary Administration	07-04	MT
Epsilon Healthcare Announces Change of Company Address	07-04	CI
Epsilon Healthcare Administrators Revert Control to Directors as DOCA Executed	06-27	MT
Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	12-19	CI
Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	12-19	CI
Epsilon Healthcare Appoints Joint and Several Administrators	12-18	MT
Epsilon Healthcare Limited Provides Information to Shareholders	12-14	CI
Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd	12-01	CI
Epsilon Healthcare Limited Announces Board Appointments	12-01	CI
Epsilon Healthcare Provides Information to Shareholders	11-22	CI
Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer	11-21	CI
Epsilon Healthcare Issues Notice of Extraordinary General Meeting	11-21	CI
Epsilon Healthcare Limited Announces Change of Address, Effective 22 November 2023	11-20	CI
Epsilon Healthcare Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23	CI
Epsilon Healthcare Rebrands Manufacturing, Telehealth Businesses	03/08/23	MT
Epsilon Healthcare Appoints CEO	19/05/23	MT
Epsilon Healthcare Appoints Peter Giannopoulos as Chief Executive Officer, Effective 23 May, 2023	19/05/23	CI
Healthcare, IT Rally Ends Australian Shares' Three-Day Losing Streak	12/05/23	MT
Epsilon Healthcare Jumps 25% After Subsidiary Renews Medicinal Cannabis Permit	12/05/23	MT
Epsilon Healthcare Limited Auditor Raises 'Going Concern' Doubt	30/03/23	CI
Epsilon Healthcare Limited Reports Earnings Results for the Full Year Ended December 31, 2022	28/02/23	CI
Epsilon Healthcare Limited Announces Executive Changes	23/12/22	CI
Epsilon Healthcare Limited Announces Company Secretary Changes	30/11/22	CI
Epsilon Healthcare Limited Appoints Mark Audet as Chief Financial Officer	30/11/22	CI

Chart Epsilon Healthcare Limited

Duration

Period

More charts

Company Profile

Epsilon Healthcare Limited is an Australia-based global healthcare and pharmaceuticals company. The Company has a diversified and vertically integrated portfolio of assets, including healthcare and pharmaceutical contract development and manufacturing. The Companyâs segments include the manufacture and distribution of hydroponics equipment, materials and nutrients, and the development and delivery of medicinal cannabis. The Company owns medicinal cannabis assets, including the GMP cannabis manufacturing facility in the Southern Hemisphere (the Southport Facility) in Southport, Australia, and the Tetra Health clinic group. The Company also provides advisory services related to medicinal cannabis. The Companyâs subsidiaries include Dragon Vision Limited, Canndeo Pty Ltd, Canna Clinics Pty Ltd, THC Pharma Pty Ltd, Metra Holdings Pty Ltd, Tetra Pty Ltd, Medimar Pty Ltd and Demimar Pty Ltd.

Sector

Pharmaceuticals

Calendar

28/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
EPSILON HEALTHCARE LIMITED	-.--%	4.85M
ELI LILLY AND COMPANY	+61.53%	848B
NOVO NORDISK A/S	+34.02%	627B
JOHNSON & JOHNSON	-3.66%	363B
MERCK & CO., INC.	+15.06%	318B
ABBVIE INC.	+9.18%	299B
ROCHE HOLDING AG	+11.33%	234B
NOVARTIS AG	+15.40%	225B
AMGEN INC.	+15.67%	179B
PFIZER, INC.	+2.47%	167B